GC Biopharma Enhances IVIG Safety with FXI Detection
YONGIN, South Korea, April 6, 2026 GC Biopharma has announced a major advancement in intravenous immunoglobulin (IVIG) safety monitoring...
IVIG
Advertisement
Kedrion Biopharma Launches YIMMUGO® for PI in the U.S.
FORT LEE, N.J., October 9, 2025 — Kedrion Biopharma today announced the U.S. commercial launch of YIMMUGO® (Immune Globulin...
Kedrion Biopharma Secures FDA Nod for QIVIGY® and Expands U.S. Growth Plan
September 29, 2025 – Kedrion Biopharma announced a major regulatory and strategic milestone with the U.S. Food and Drug...
Advertisement
